Home

Insights

PE

Godavari Drugs Ltd P/E Ratio

Godavari Drugs Ltd P/E Ratio

download
stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

20.5 K

stocks traded

Last Updated time: 16 Jul 11:24 AM

Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

PE

14.1

Last updated : 16 Jul 11:24 AM

Key Highlights

    The P/E Ratio of Godavari Drugs Ltd is 14.1 as of 16 Jul 11:24 AM .a1#The P/E Ratio of Godavari Drugs Ltd changed from 14.6 on March 2019 to 15.1 on March 2023 . This represents a CAGR of 0.68% over 5 years. a1#The Latest Trading Price of Godavari Drugs Ltd is ₹ 107 as of 16 Jul 11:18 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.5. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 35.8. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Godavari Drugs Ltd changed from ₹ 17.58 crore on March 2019 to ₹ 57.03 crore on March 2023 . This represents a CAGR of 26.54% over 5 years. a1#The Revenue of Godavari Drugs Ltd changed from ₹ 42.62 crore to ₹ 38.75 crore over 8 quarters. This represents a CAGR of -4.65% a1#The EBITDA of Godavari Drugs Ltd changed from ₹ 2.47 crore to ₹ 4.55 crore over 8 quarters. This represents a CAGR of 35.72% a1#The Net Pr of Godavari Drugs Ltd changed from ₹ 0.92 crore to ₹ 2.66 crore over 8 quarters. This represents a CAGR of 70.04% a1#The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Godavari Drugs Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Godavari Drugs Ltd

Period
Mar '1914.6
Mar '204.3
Mar '218.4
Mar '229.4
Mar '2315.1

Company Fundamentals for Godavari Drugs Ltd

Market Cap

79 Cr

EPS

7.5

P/E Ratio (TTM) *

14.1

P/B Ratio (TTM) *

2.0

Day’s High

108.25

Day’s Low

105.9

DTE *

1.4

ROE *

14.2

52 Week High

114.0

52 Week Low

82.1

ROCE *

12.5

* All values are consolidated

Last Updated time: 16 Jul 11:24 AM

* All values are consolidated

Last Updated time: 16 Jul 11:24 AM

Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

PRICE

107

1.40 (1.33%)

stock direction

Last updated : 16 Jul 11:18

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Godavari Drugs Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Godavari Drugs Ltd

Market Value

80

-0.1 X

Value addition

Asset Value

87

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Godavari Drugs Ltd1479
Sun Pharmaceuticals Industries Ltd38380,451
Cipla Ltd28122,424
Divis Laboratories Ltd75121,461
Zydus Lifesciences Ltd31119,531
Dr Reddys Laboratories Ltd20113,324

Key Valuation Metric of Godavari Drugs Ltd

Earnings

5 Cr

14.1 X

PE Ratio

Market Cap

₹79.52Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

5 Cr

14.1 X

PE Ratio

Market Cap

₹79.52Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Godavari Drugs Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Godavari Drugs Ltd

Period
Mar '1918
Mar '209
Mar '2134
Mar '2249
Mar '2357

* All values are a in crore

×

Historical Revenue of Godavari Drugs Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Godavari Drugs Ltd

Period
Jun '2243
Sep '2241
Dec '2239
Mar '2338
Jun '2336
Sep '2340
Dec '2343
Mar '2439

* All values are a in crore

×

Historical EBITDA of Godavari Drugs Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Godavari Drugs Ltd

Period
Jun '222
Sep '223
Dec '223
Mar '233
Jun '233
Sep '233
Dec '234
Mar '245

* All values are a in crore

×

Historical Net Profit of Godavari Drugs Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Godavari Drugs Ltd

Period
Jun '221
Sep '221
Dec '221
Mar '231
Jun '231
Sep '231
Dec '231
Mar '243

* All values are a in crore

×

Historical Dividend Payout of Godavari Drugs Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Godavari Drugs Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Godavari Drugs Ltd

About Godavari Drugs Ltd

    Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug. The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale to pilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.

Godavari Drugs Ltd News Hub

News

Godavari Drugs to conduct AGM

Godavari Drugs announced that the 36th Annual General Meeting (AGM) of the company will be...

Read more

28 Jun 202418:50

News

Godavari Drugs to convene board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024...

Read more

29 May 202413:53

News

Godavari Drugs revises board meeting date

Godavari Drugs has revised the meeting of the Board of Directors which was scheduled to be...

Read more

08 Feb 202412:02

News

Godavari Drugs announces board meeting date

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 February...

Read more

07 Feb 202416:30

News

Godavari Drugs to conduct board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November...

Read more

08 Nov 202315:27

News

Godavari Drugs to table results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 11 August 2...

Read more

07 Aug 202312:23

Product Composition by Percentage (Revenue)

FAQs for PE of Godavari Drugs Ltd

What is Godavari Drugs Ltd current share price?

The current market price of Godavari Drugs Ltd as of July 16, 2024 is ₹107.00.

What is Godavari Drugs Ltd's market cap?

Godavari Drugs Ltd's market capitalisation stood at ₹79 Cr as of July 16, 2024

What are Godavari Drugs Ltd's total net assets?

According to Godavari Drugs Ltd's most recent financial filings, the company's net assets total ₹87.0 Cr.

Is Godavari Drugs Ltd making a profit or loss?

Godavari Drugs Ltd's net Profit as of July 16, 2024 is close to ₹5 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199